“Dapagliflozin in Heart Failure with Reduced Ejection Fraction (HFrEF): A Systematic Review of Its Mechanisms and Clinical Effectiveness”, JPS, vol. 8, no. 4, pp. 2339–2347, Oct. 2025, doi: 10.36490/journal-jps.com.v8i4.1121.